At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- Doctors Explain How to Tell the Difference Between Cold, Flu, and COVID-19 Symptoms.
- NJACTS Community Engagement Core COVID-19 Resources
- Join NJ ACTS Biostatistics, Epidemiology, Research Design (BERD)on 5/28 at 12pm
- Local infectious disease doctor says Hantavirus risk to public remains low.
- Join RITMS for a Faculty Candidate Talk on 5/13 at 2pm
Categories
- Community (2,489)
- Covid (1,001)
- CTO Events (6)
- News (3,159)
- Pilots (21)